Press Release
| << Back |
Align Technology Announces Third Quarter 2026 Financial Results
Clear Aligner Revenue Growth, Improved Profitability and Continued Capital Return Demonstrate Progress on Strategic Priorities
-
Q3'26 total revenues were
$1.015 billion , up 1.9% year-over-year -
Q3'26 Clear Aligner revenues of
$839.3 million increased 4.2% year-over-year, and Clear Aligner volume increased 6.6% year-over-year to 690.6 thousand cases -
Q3'26 Imaging Systems and CAD/CAM Services revenues were
$175.5 million , down 7.6% year-over-year - Q3'26 gross margin was 68.7%. On a non-GAAP basis, Q3'26 gross margin was 70.4%(1), flat year-over-year or up approximately 0.7 points at constant currency
- Q3'26 operating margin was 16.7%, compared with 9.7% in Q3'25. Non-GAAP operating margin was 24.4%(1), up 0.5 points year-over-year or up approximately 1.4 points at constant currency
-
Q3'26 diluted net income per share was
$1.90 , compared with$0.78 in Q3'25. Non-GAAP diluted net income per share was$2.80 (1), compared with$2.61 in Q3'25
Commenting on Align's Q3'26 results,
Continued Hogan, "We also have a significant innovation pipeline ahead of us. We continue to be excited about our next-gen direct fabrication 3D printing materials platform, called NXT Technology. NXT Technology unlocks greater control, consistency, and precision across appliance design-enabling an entirely new level of Invisalign® performance and personalization. We are broadening the application of 3D printing across the Invisalign portfolio, as well as expanding into new categories: Invisalign® Specifix attachment system expands our direct 3D-printing capabilities beyond aligners and appliances into the attachment system itself. This week, we will begin a
Q3'26 total revenues were
Q3'26 gross profit was
Q3'26 operating income was
|
(1) |
For more information, please see the tables captioned "Unaudited GAAP to Non-GAAP Reconciliation." |
Financial Summary - Third Quarter Fiscal 2026
|
|
Q3'26 |
Q2'26 |
Q3'25 |
Q/Q Change |
Y/Y Change |
||||||||||
|
Clear Aligner Shipments |
|
690,635 |
|
691,785 |
|
647,750 |
(0.2 |
)% |
+6.6% |
||||||
|
GAAP |
|
|
|
|
|
||||||||||
|
Net Revenues |
|
|
|
(3.9 |
)% |
+1.9% |
|||||||||
|
Clear Aligner |
|
|
|
(3.6 |
)% |
+4.2% |
|||||||||
|
Imaging Systems and CAD/CAM Services |
|
|
|
(5.3 |
)% |
(7.6 |
)% |
||||||||
|
Net Income |
|
|
|
+24.7% |
+138.0% |
||||||||||
|
Diluted EPS |
$ |
1.90 |
$ |
1.51 |
$ |
0.78 |
|
|
|||||||
|
Non-GAAP |
|
|
|
|
|
||||||||||
|
Net Income |
|
|
|
+5.2% |
+5.2% |
||||||||||
|
Diluted EPS |
$ |
2.80 |
$ |
2.64 |
$ |
2.61 |
|
|
|||||||
|
Changes and percentages are calculated using unrounded values. As a result, certain tables may not sum or recalculate precisely due to rounding. |
|||||||||||||||
As of
Commenting on Align's performance and business outlook, Align Technology CFO and EVP Global Finance,
Align Announcement Highlights –Link to Align press release page: https://investor.aligntech.com/
Q3'26 Stock Repurchase
-
During Q3'26, we repurchased approximately 627.3 thousand shares of our common stock at an average price of
$164.73 per share. These purchases were made pursuant to the$200.0 million open market repurchase plan announced onApril 29, 2026 , which we completed earlier this month. -
As of
September 30, 2026 ,$630.0 million remains available for repurchases of our common stock under our$1.0 billion stock repurchase program announced inApril 2025 . -
During Q4'26, we expect to repurchase up to
$300.0 million of our common stock.
Fiscal 2026 Business Outlook
Assuming no circumstances occur beyond our control that could impact our business:
Q4'26:
-
We expect Q4’26 worldwide revenues to be in the range of
$1,000M to$1,020M . - We expect Q4'26 Clear Aligner volume to be up low single-digits year-over-year and Q4'26 Clear Aligner ASP to be down approximately 1% year-over-year.
-
We expect Q4'26
Systems & Services revenue to be in the range of$170M to$180M . - We expect Q4’26 GAAP Gross Margin to be approximately 71.0%.
- We expect Q4’26 non-GAAP Gross Margin to be approximately 72.0%.
- We expect Q4’26 GAAP Operating Margin to be approximately 20.0%.
- We expect Q4’26 non-GAAP Operating Margin to be approximately 26.0%.
-
For Q4’26, we expect to repurchase up to
$300M of our common stock.
For Fiscal 2026:
-
We expect 2026 worldwide revenue to be approximately in the range of
$4,110M to$4,130M . - We expect 2026 Clear Aligner volume and revenue growth to be up approximately 5% to 6% year-over-year.
- We expect 2026 Clear Aligner ASP to be slightly down from 2025.
-
We expect 2026
Systems & Services revenue to be$715M to$725M . - We expect 2026 GAAP Operating Margin to be approximately 16.2%, up approximately 2.7 points year-over-year.
- We expect 2026 non-GAAP Operating Margin to be approximately 23.7%, a 100-basis point improvement year-over-year consistent with our previous guidance.
-
We expect our investments in capital expenditures for fiscal 2026 to be
$125M to$150M . -
We expect to repurchase approximately
$500M of our common stock in 2026, reflecting the conviction of the Board and Management in Align's long-term value.
Third Quarter 2026 Highlights:
- Q3’26 Clear Aligner growth initiatives continued to expand the number of doctors submitting cases and support broader access to Invisalign® treatment with doctor utilization increasing 3.4% year-over-year.
- Q3’26 iTero™ scanner units placed including leased, rented and certified pre-owned systems, increased double-digits year-over-year to more than 157,000 systems globally.
-
Significant innovation pipeline across digital treatment planning, AI-enabled capabilities, growing-patient treatment, restorative workflows, scanning solutions and
CAD/CAM software. We are investing in technologies that can expand clinical applicability, improve the customer experience and make our business more productive at scale. -
Next-gen direct fabrication 3D printing and new materials called NXT Technology. NXT unlocks greater control, consistency, and precision across appliance design-enabling an entirely new level of Invisalign® performance and personalization. Invisalign® Specifix attachment system launched this year expands our direct 3D-printing capabilities beyond aligners and appliances into the attachment system itself. We are launching a
U.S . pilot of a new product category -- sports mouth guards -- powered by our direct 3D printing technology, and material science capabilities. Sports mouth guards represent a large and growing market opportunity amid growing awareness of concussion risks in contact sports. The Invisalign® Sports Guard is a custom direct 3D printed sports mouth guard made from an iTero™ digital scan. It comes in multiple thickness options, and will be available through participating Invisalign providers. For more information please email: invisalignsportsguard@aligntech.com.
Align Webcast and Conference Call
We will host a conference call today,
About Non-GAAP Financial Measures
To supplement our consolidated financial statements, which are prepared and presented in accordance with generally accepted accounting principles ("GAAP") in
Our management believes that the use of certain non-GAAP financial measures provides meaningful supplemental information regarding our recurring core operating performance. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting, and analyzing future periods. We believe these non-GAAP financial measures are useful to investors because (1) they allow for greater transparency with respect to key metrics used by management in its financial and operational decision-making, and (2) they are used by our institutional investors and the analyst community to help them analyze the performance of our business.
There are material limitations to using non-GAAP financial measures as they are not prepared in accordance with
About Align Technology, Inc.
Align Technology designs and manufactures the Invisalign® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 307 thousand doctor customers and are key to accessing Align’s 600 million consumer market opportunity worldwide. Over the past 29 years, Align has helped doctors treat approximately 24.2 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align™ Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit www.aligntech.com for more information.
For additional information about the Invisalign System or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about the iTero digital scanning system, please visit www.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit www.exocad.com.
Invisalign, iTero, exocad, Align, Align Digital Platform and iTero Lumina are trademarks of Align Technology, Inc.
Forward-Looking Statements
This press release, including the tables below, contains forward-looking statements, including statements of our current intentions, beliefs and expectations regarding our products and innovations, market opportunities; our flexibility to invest in innovation, support our customers, and return capital to shareholders, and our commitment to disciplined capital allocation, financial flexibility and the creation of long-term value for shareholders; our expectations for Q4'26 worldwide revenues, Clear Aligner volume, Clear Aligner ASP, Systems and Services revenues, GAAP and non-GAAP gross margin, and GAAP and non-GAAP operating margin; our expectations for fiscal year 2026 worldwide revenue growth (including our assumption regarding foreign exchange), Clear Aligner volume growth, Clear Aligner ASP, Systems and Services revenue growth, GAAP and non-GAAP gross margin, GAAP and non-GAAP operating margin; our expectations regarding the timing and amount of future stock repurchases, including our plans to repurchase $500 million of our common stock in 2026; and our expectation that our fiscal 2027 GAAP and non-GAAP operating margins will improve by approximately 100 basis points year-over-year. Forward-looking statements contained in this press release are based upon information available to Align as of the date hereof. These forward-looking statements reflect our best judgments based on currently known facts and circumstances and are subject to risks and uncertainties, and assumptions that may be inaccurate. As a result, actual results may differ materially and adversely from those expressed or implied in any forward-looking statement.
Factors that might cause such a difference include, but are not limited to:
- macroeconomic conditions, including fluctuations in foreign currency exchange rates, higher interest rates, market volatility, inflation, general economic weakness, and threats of or actual slowdowns or recessions;
- geopolitical events, such as wars, military conflicts (such as the ongoing military conflicts in the Middle East, including the hostilities involving Israel, Iran, and the United States, and geopolitical tensions involving Ukraine and China), terrorism and major public health crises, which could result in, among other things, disruptions to our supply chain and the global economy, energy shortages and elevated gasoline and other energy costs, inflation, decreased customer and consumer sentiment, uneven patient traffic at dental practices, and a shift in public opinion about companies based in the United States or in the regions where we operate;
- trade policies, tariffs, customs duties and fees, and retaliatory actions, international trade disputes, or protectionist trade measures taken in response to or resulting from such measures;
- customer and consumer purchasing behavior and changes in demand for dental services as a result of, among other things, prevailing macroeconomic conditions, declining customer confidence and consumer sentiment, consumer economic uncertainty, employment levels, health insurance coverage, wages, debt obligations, discretionary income, inflationary pressure, and perceptions of current and future economic conditions;
- variations in our geographic, channel or product mix, product launches, product pilots and product adoption, and selling prices regionally and globally, including product mix shifts to lower priced products or to products and leasing or rental programs with a higher percentage of deferred revenue;
- reductions, delays or shifts in purchasing or utilization of our products and services by doctors at dental support organizations, orthodontic service organizations and other large group practices;
- competition from existing and new competitors;
- competitive pressure from AI-powered technologies in the dental industry, regulatory and legal risks surrounding implementation of AI, and reputational harm from improper use of AI;
- declines in, or the slowing of the growth of, sales of our clear aligners and intraoral scanners domestically and/or internationally and the impact either would have on the adoption of Invisalign products;
- the possibility that the development and release of new products or enhancements to existing products do not proceed in accordance with the anticipated timeline or may themselves contain bugs, errors, or defects in software or hardware requiring remediation and that the market for the sale of these new or enhanced products may not develop as expected;
- the timing, availability and cost of raw materials, components, products and other shipping and supply chain constraints and disruptions;
- unexpected or rapid changes in the growth or decline of our domestic and/or international markets;
- rapidly evolving and groundbreaking advances that fundamentally alter the dental industry or the way new and existing customers market and provide products and services to consumers;
- our ability to protect our intellectual property rights;
- our ability to comply with regulatory requirements and obtain and maintain regulatory approvals or clearances, including as a result of any shutdowns of the U.S. federal government or reductions in government personnel;
- the willingness and ability of our customers to maintain and/or increase product utilization in sufficient numbers;
- our ability to sustain or increase profitability or revenue growth in future periods (or minimize declines) while controlling expenses;
- expansion of our business and products;
- our ability to identify, complete, finance and integrate acquisitions, investments and other strategic transactions, and to realize the anticipated synergies and benefits of those transactions;
- the impact of excess or constrained capacity at our manufacturing and treat operations facilities and pressure on our internal systems and personnel;
- security breaches, data breaches, or other cybersecurity incidents involving any customer and/or patient data, and our failure to comply with laws, regulations and other obligations related to privacy, data protection, data governance and cybersecurity;
- natural disasters and extreme weather conditions occurring in a region where one of our facilities or those of our customers or suppliers are located;
- the timing of case submissions from our doctor customers within a quarter as well as increases in manufacturing cost per case; and
- the loss of key personnel, labor shortages, or work stoppages for us or our suppliers.
The foregoing and other risks are detailed from time to time in our periodic reports filed with the Securities and Exchange Commission, including, but not limited to, our Annual Report on Form 10-K for the year ended December 31, 2025, which was filed with the Securities and Exchange Commission ("SEC") on February 27, 2026 and our latest Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, which was filed with the SEC on August 5, 2026. Align undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
|
|
|||||||||||||||
|
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
|||||||||||||||
|
(in thousands, except per share data) |
|||||||||||||||
|
|
Three Months Ended
|
Nine Months Ended
|
|||||||||||||
|
|
2026 |
2025 |
2026 |
2025 |
|||||||||||
|
Net revenues |
$ |
1,014,763 |
|
$ |
995,692 |
|
$ |
3,111,042 |
|
$ |
2,987,403 |
||||
|
Cost of net revenues |
|
317,292 |
|
|
356,491 |
|
|
919,554 |
|
|
959,977 |
||||
|
Gross profit |
|
697,471 |
|
|
639,201 |
|
|
2,191,488 |
|
|
2,027,426 |
||||
|
Operating expenses: |
|
|
|
|
|||||||||||
|
Selling, general and administrative |
|
410,554 |
|
|
417,800 |
|
|
1,338,567 |
|
|
1,314,115 |
||||
|
Research and development |
|
93,873 |
|
|
93,276 |
|
|
294,563 |
|
|
286,875 |
||||
|
Restructuring and other charges |
|
17,231 |
|
|
31,827 |
|
|
17,231 |
|
|
31,827 |
||||
|
Legal settlements and contingencies |
|
6,649 |
|
|
— |
|
|
75,995 |
|
|
4,178 |
||||
|
Total operating expenses |
|
528,307 |
|
|
542,903 |
|
|
1,726,356 |
|
|
1,636,995 |
||||
|
Income from operations |
|
169,164 |
|
|
96,298 |
|
|
465,132 |
|
|
390,431 |
||||
|
Interest income and other income (expense), net: |
|
|
|
|
|||||||||||
|
Interest income |
|
6,212 |
|
|
3,249 |
|
|
14,759 |
|
|
11,424 |
||||
|
Other income (expense), net |
|
(5,302 |
) |
|
(4,813 |
) |
|
(12,238 |
) |
|
6,837 |
||||
|
Total interest income and other income (expense), net |
|
910 |
|
|
(1,564 |
) |
|
2,521 |
|
|
18,261 |
||||
|
Net income before provision for income taxes |
|
170,074 |
|
|
94,734 |
|
|
467,653 |
|
|
408,692 |
||||
|
Provision for income taxes |
|
35,030 |
|
|
37,981 |
|
|
111,544 |
|
|
134,101 |
||||
|
Net income |
$ |
135,044 |
|
$ |
56,753 |
|
$ |
356,109 |
|
$ |
274,591 |
||||
|
|
|
|
|
|
|||||||||||
|
Net income per share: |
|
|
|
|
|||||||||||
|
Basic |
$ |
1.90 |
|
$ |
0.78 |
|
$ |
4.99 |
|
$ |
3.77 |
||||
|
Diluted |
$ |
1.90 |
|
$ |
0.78 |
|
$ |
4.98 |
|
$ |
3.77 |
||||
|
Shares used in computing net income per share: |
|
|
|
|
|||||||||||
|
Basic |
|
70,993 |
|
|
72,377 |
|
|
71,303 |
|
|
72,831 |
||||
|
Diluted |
|
71,015 |
|
|
72,419 |
|
|
71,473 |
|
|
72,880 |
||||
|
|
||||||
|
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS |
||||||
|
(in thousands) |
||||||
|
|
|
|
||||
|
ASSETS |
|
|
||||
|
|
|
|
||||
|
Current assets: |
|
|
||||
|
Cash and cash equivalents |
$ |
1,144,931 |
$ |
1,094,908 |
||
|
Accounts receivable, net |
|
1,163,854 |
|
1,101,757 |
||
|
Inventories |
|
224,654 |
|
226,343 |
||
|
Prepaid expenses and other current assets |
|
192,636 |
|
165,571 |
||
|
Assets held for sale |
|
— |
|
27,983 |
||
|
Total current assets |
|
2,726,075 |
|
2,616,562 |
||
|
|
|
|
||||
|
Property, plant and equipment, net |
|
1,134,486 |
|
1,131,453 |
||
|
Operating lease right-of-use assets, net |
|
140,616 |
|
108,322 |
||
|
|
|
495,279 |
|
491,833 |
||
|
Intangible assets, net |
|
90,620 |
|
93,933 |
||
|
Deferred tax assets |
|
1,478,052 |
|
1,513,542 |
||
|
Other assets |
|
455,481 |
|
278,048 |
||
|
|
|
|
||||
|
Total assets |
$ |
6,520,609 |
$ |
6,233,693 |
||
|
|
|
|
||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
||||
|
|
|
|
||||
|
Current liabilities: |
|
|
||||
|
Accounts payable |
$ |
117,876 |
$ |
121,450 |
||
|
Accrued liabilities |
|
633,487 |
|
536,749 |
||
|
Deferred revenues |
|
1,162,134 |
|
1,261,816 |
||
|
Total current liabilities |
|
1,913,497 |
|
1,920,015 |
||
|
|
|
|
||||
|
Income tax payable |
|
72,138 |
|
68,200 |
||
|
Operating lease liabilities |
|
112,296 |
|
82,507 |
||
|
Other long-term liabilities |
|
117,101 |
|
113,824 |
||
|
Total liabilities |
|
2,215,032 |
|
2,184,546 |
||
|
|
|
|
||||
|
Total stockholders’ equity |
|
4,305,577 |
|
4,049,147 |
||
|
|
|
|
||||
|
Total liabilities and stockholders’ equity |
$ |
6,520,609 |
$ |
6,233,693 |
||
|
|
||||||||
|
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
||||||||
|
(in thousands) |
||||||||
|
|
Nine Months Ended
|
|||||||
|
|
2026 |
2025 |
||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES |
|
|
||||||
|
Net cash provided by operating activities |
$ |
526,716 |
|
$ |
370,046 |
|
||
|
|
|
|
||||||
|
CASH FLOWS FROM INVESTING ACTIVITIES |
|
|
||||||
|
Net cash used in investing activities |
|
(260,797 |
) |
|
(76,529 |
) |
||
|
|
|
|
||||||
|
CASH FLOWS FROM FINANCING ACTIVITIES |
|
|
||||||
|
Net cash used in financing activities |
|
(210,493 |
) |
|
(367,174 |
) |
||
|
|
|
|
||||||
|
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash |
|
(5,324 |
) |
|
34,502 |
|
||
|
Net increase (decrease) in cash, cash equivalents, and restricted cash |
|
50,102 |
|
|
(39,155 |
) |
||
|
Cash, cash equivalents, and restricted cash at beginning of the period |
|
1,096,186 |
|
|
1,044,963 |
|
||
|
Cash, cash equivalents, and restricted cash at end of the period |
$ |
1,146,288 |
|
$ |
1,005,808 |
|
||
|
|
||||||||||||||||||||||||
|
INVISALIGN BUSINESS METRICS |
||||||||||||||||||||||||
|
|
Q1 |
Q2 |
Q3 |
Q4 |
Fiscal |
Q1 |
Q2 |
Q3 |
||||||||||||||||
|
|
2025 |
2025 |
2025 |
2025 |
2025 |
2026 |
2026 |
2026 |
||||||||||||||||
|
Number of Invisalign Trained Doctors Cases Were Shipped To |
|
|
|
|
|
|||||||||||||||||||
|
|
|
85,275 |
|
86,250 |
|
88,155 |
|
87,710 |
|
130,015 |
|
88,065 |
|
89,175 |
|
90,910 |
||||||||
|
Invisalign Trained Doctor Utilization Rates* |
|
|
|
|
|
|||||||||||||||||||
|
|
|
7.5 |
|
7.5 |
|
7.3 |
|
7.7 |
|
20.1 |
|
7.8 |
|
7.8 |
|
7.6 |
||||||||
|
Clear Aligner Revenue Per Case Shipment** |
|
|
|
|
|
|||||||||||||||||||
|
|
$ |
1,240 |
$ |
1,250 |
$ |
1,245 |
$ |
1,240 |
$ |
1,245 |
$ |
1,250 |
$ |
1,260 |
$ |
1,215 |
||||||||
|
* number of cases shipped / number of doctors to whom cases were shipped |
||||||||||||||||||||||||
|
** Clear Aligner revenues / Case shipments |
||||||||||||||||||||||||
|
|
||||||||||||||||||||||||
|
STOCK-BASED COMPENSATION |
||||||||||||||||||||||||
|
(in thousands) |
||||||||||||||||||||||||
|
|
Q1 |
Q2 |
Q3 |
Q4 |
Fiscal |
Q1 |
Q2 |
Q3 |
||||||||||||||||
|
|
2025 |
2025 |
2025 |
2025 |
2025 |
2026 |
2026 |
2026 |
||||||||||||||||
|
Stock-based Compensation (SBC): |
|
|
|
|
|
|
|
|
||||||||||||||||
|
SBC included in Gross Profit |
$ |
1,538 |
$ |
1,636 |
$ |
1,540 |
$ |
1,463 |
$ |
6,177 |
$ |
1,620 |
$ |
1,846 |
$ |
1,819 |
||||||||
|
SBC included in Operating Expenses |
|
43,459 |
|
46,572 |
|
46,837 |
|
42,825 |
|
179,693 |
|
39,304 |
|
43,714 |
|
37,208 |
||||||||
|
Total SBC |
$ |
44,997 |
$ |
48,208 |
$ |
48,377 |
$ |
44,288 |
$ |
185,870 |
$ |
40,924 |
$ |
45,560 |
$ |
39,027 |
||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
|
||||||||||||||||||
|
UNAUDITED GAAP TO NON-GAAP RECONCILIATION+ |
||||||||||||||||||
|
CONSTANT CURRENCY NET REVENUES, GROSS PROFIT AND GROSS MARGIN |
||||||||||||||||||
|
(in thousands, except percentages) |
||||||||||||||||||
|
Sequential constant currency analysis: |
||||||||||||||||||
|
|
Three Months Ended |
|||||||||||||||||
|
|
|
|
|
|||||||||||||||
|
|
GAAP |
Constant Currency Impact |
Constant Currency Totals |
GAAP |
Impact of Constant Currency |
|||||||||||||
|
Net revenues |
|
|
|
|
|
|||||||||||||
|
Clear Aligner |
$ |
839,272 |
|
$ |
3,799 |
$ |
843,071 |
|
$ |
870,874 |
|
|
||||||
|
|
|
175,491 |
|
|
903 |
|
176,394 |
|
|
185,318 |
|
|
||||||
|
Total net revenues1 |
$ |
1,014,763 |
|
$ |
4,702 |
$ |
1,019,465 |
|
$ |
1,056,192 |
|
0.5 |
% |
|||||
|
Gross profit |
|
|
|
|
|
|||||||||||||
|
Clear Aligner |
$ |
581,357 |
|
$ |
3,722 |
$ |
585,079 |
|
$ |
621,504 |
|
|
||||||
|
|
|
116,114 |
|
|
752 |
|
116,866 |
|
|
135,926 |
|
|
||||||
|
Total gross profit2 |
$ |
697,471 |
|
$ |
4,474 |
$ |
701,945 |
|
$ |
757,430 |
|
|
||||||
|
Gross margin |
|
|
|
|
|
|||||||||||||
|
Clear Aligner |
|
69.3 |
% |
|
|
69.4 |
% |
|
71.4 |
% |
0.1 |
|
||||||
|
|
|
66.2 |
% |
|
|
66.3 |
% |
|
73.3 |
% |
0.1 |
|
||||||
|
Consolidated gross margin3 |
|
68.7 |
% |
|
|
68.9 |
% |
|
71.7 |
% |
0.1 |
|
||||||
|
Year-over-year constant currency analysis: |
||||||||||||||||||
|
|
Three Months Ended |
|||||||||||||||||
|
|
2026 |
2025 |
|
|||||||||||||||
|
|
GAAP |
Constant Currency Impact |
Constant Currency Totals |
GAAP |
Impact of Constant Currency |
|||||||||||||
|
Net revenues |
|
|
|
|
|
|||||||||||||
|
Clear Aligner |
$ |
839,272 |
|
$ |
4,082 |
$ |
843,354 |
|
$ |
805,799 |
|
|
||||||
|
|
|
175,491 |
|
|
901 |
|
176,392 |
|
|
189,893 |
|
|
||||||
|
Total net revenues1 |
$ |
1,014,763 |
|
$ |
4,983 |
$ |
1,019,746 |
|
$ |
995,692 |
|
0.5 |
% |
|||||
|
Gross profit |
|
|
|
|
|
|||||||||||||
|
Clear Aligner |
$ |
581,357 |
|
$ |
9,717 |
$ |
591,074 |
|
$ |
522,858 |
|
|
||||||
|
|
|
116,114 |
|
|
1,630 |
|
117,744 |
|
|
116,343 |
|
|
||||||
|
Total gross profit2 |
$ |
697,471 |
|
$ |
11,347 |
$ |
708,818 |
|
$ |
639,201 |
|
|
||||||
|
Gross margin |
|
|
|
|
|
|||||||||||||
|
Clear Aligner |
|
69.3 |
% |
|
|
70.1 |
% |
|
64.9 |
% |
0.8 |
|
||||||
|
|
|
66.2 |
% |
|
|
66.8 |
% |
|
61.3 |
% |
0.6 |
|
||||||
|
Consolidated gross margin3 |
|
68.7 |
% |
|
|
69.5 |
% |
|
64.2 |
% |
0.8 |
|
||||||
|
Note: |
||
|
(1) |
We define constant currency net revenues as total net revenues excluding the effect of foreign exchange rate movements and use it to determine the percentage for the constant currency impact on net revenues on a sequential and year-over-year basis. Constant currency impact in dollars is calculated by translating the current period GAAP net revenues using the foreign currency exchange rates that were in effect during the previous comparable period and subtracting it by the current period GAAP net revenues. The percentage for the constant currency impact on net revenues is calculated by dividing the constant currency impact in dollars (numerator) by constant currency net revenues in dollars (denominator). |
|
|
(2) |
We define constant currency gross profit as GAAP gross profit excluding the impacts of foreign exchange rate fluctuations on net revenues and cost of net revenues. |
|
|
(3) |
We define constant currency gross margin as constant currency gross profit as a percentage of constant currency net revenues. Gross margin constant currency impact is the increase or decrease in constant currency gross margin compared to the GAAP gross margin. |
|
|
(+) |
Changes and percentages are based on actual values. Certain tables may not sum or recalculate due to rounding. Refer to "About Non-GAAP Financial Measures" section of press release. |
|
|
|
||||||
|
UNAUDITED GAAP TO NON-GAAP RECONCILIATION CONTINUED+ |
||||||
|
CONSTANT CURRENCY INCOME FROM OPERATIONS AND OPERATING MARGIN |
||||||
|
(in thousands, except percentages) |
||||||
|
Sequential constant currency analysis: |
||||||
|
|
Three Months Ended |
|||||
|
|
|
|
||||
|
GAAP income from operations |
$ |
169,164 |
$ |
154,013 |
||
|
Income from operations constant currency impact (1) |
|
2,733 |
|
|||
|
Constant currency income from operations (1) |
$ |
171,897 |
|
|||
|
|
Three Months Ended |
|||
|
|
|
|
||
|
GAAP operating margin |
16.7% |
14.6% |
||
|
Operating margin constant currency impact (2) |
0.2 |
|
||
|
Constant currency operating margin (2) |
16.9% |
|
||
|
Year-over-year constant currency analysis: |
||||||
|
|
Three Months Ended
|
|||||
|
|
2026 |
2025 |
||||
|
GAAP income from operations |
$ |
169,164 |
$ |
96,298 |
||
|
Income from operations constant currency impact (1) |
|
16,059 |
|
|||
|
Constant currency income from operations (1) |
$ |
185,223 |
|
|||
|
|
Three Months Ended
|
|||
|
|
2026 |
2025 |
||
|
GAAP operating margin |
16.7% |
9.7% |
||
|
Operating margin constant currency impact (2) |
1.5 |
|
||
|
Constant currency operating margin (2) |
18.2% |
|
||
|
Notes: |
||
|
(1) |
Beginning in Q1 2026, we define constant currency income from operations as GAAP income from operations excluding the effect of foreign exchange rate movements for GAAP gross profit and operating expenses on a sequential and year-over-year basis. Constant currency impact in dollars is calculated by translating the current period gross profit and operating expenses using the foreign currency exchange rates that were in effect during the previous comparable period and subtracting it by the current period GAAP net revenues and operating expenses. |
|
|
(2) |
We define constant currency operating margin as constant currency income from operations as a percentage of constant currency net revenues. Operating margin constant currency impact is the increase or decrease in constant currency operating margin compared to the GAAP operating margin. |
|
|
(+) |
Changes and percentages are based on actual values. Certain tables may not sum or recalculate due to rounding. Refer to "About Non-GAAP Financial Measures" section of press release. |
|
|
|
||||||
|
UNAUDITED GAAP TO NON-GAAP RECONCILIATION CONTINUED+ |
||||||
|
CONSTANT CURRENCY DILUTED NET INCOME PER SHARE |
||||||
|
(in dollars) |
||||||
|
Sequential constant currency analysis: |
||||||
|
|
Three Months Ended |
|||||
|
|
|
|
||||
|
GAAP diluted net income per share |
$ |
1.90 |
$ |
1.51 |
||
|
Diluted net income per share constant currency impact (1) |
|
0.09 |
|
|||
|
Constant currency diluted net income per share (1) |
$ |
1.99 |
|
|||
|
Year-over-year constant currency analysis: |
||||||
|
|
Three Months Ended
|
|||||
|
|
2026 |
2025 |
||||
|
GAAP diluted net income per share |
$ |
1.90 |
$ |
0.78 |
||
|
Diluted net income per share constant currency impact (1) |
|
0.24 |
|
|||
|
Constant currency diluted net income per share (1) |
$ |
2.14 |
|
|||
|
Notes: |
||
|
(1) |
Constant currency diluted net income per share is computed by dividing GAAP net income excluding the impacts of foreign exchange rate fluctuations on GAAP operating income and non-operating income and expense by the weighted average diluted shares outstanding during the period. Diluted net income per share constant currency impact is the increase or decrease in constant currency diluted net income per share compared to the GAAP diluted net income per share. |
|
|
(+) |
Changes and percentages are based on actual values. Certain tables may not sum or recalculate due to rounding. Refer to "About Non-GAAP Financial Measures" section of press release. |
|
|
|
|||
|
UNAUDITED CONSTANT CURRENCY IMPACT ON NON-GAAP ITEMS+ |
|||
|
Year-over-year constant currency analysis |
Three Months Ended
|
||
|
Non-GAAP gross profit |
$ |
714,079 |
|
|
Constant currency impact on non-GAAP gross profit(1) |
|
10,451 |
|
|
Non-GAAP constant currency gross profit(1) |
$ |
724,530 |
|
|
Year-over-year constant currency analysis |
Three Months Ended
|
|
|
Non-GAAP gross margin |
70.4% |
|
|
Non-GAAP gross margin constant currency impact(1) |
0.7 |
|
|
Non-GAAP constant currency gross margin(1) |
71.1% |
|
|
Year-over-year constant currency analysis |
Three Months Ended
|
||
|
Non-GAAP income from operations |
$ |
247,790 |
|
|
Constant currency impact on non-GAAP income from operations(2) |
|
15,205 |
|
|
Non-GAAP constant currency income from operations(2) |
$ |
262,995 |
|
|
Year-over-year constant currency analysis |
Three Months Ended
|
|
|
Non-GAAP operating margin |
24.4% |
|
|
Non-GAAP operating margin constant currency impact |
1.4 |
|
|
Non-GAAP constant currency operating margin |
25.8% |
|
Notes: |
||
|
(1) |
We define Non-GAAP constant currency gross profit as Non-GAAP gross profit, as reconciled to GAAP gross profit, excluding the impacts of foreign exchange rate fluctuations on Non-GAAP gross profit. We define Non-GAAP constant currency gross margin as Non-GAAP constant currency gross profit as a percentage of constant currency net revenues. |
|
|
(2) |
We define Non-GAAP constant currency income from operations as Non-GAAP income from operations, as reconciled to GAAP income from operations, excluding the impacts of foreign exchange rate fluctuations on Non-GAAP income from operations. We define Non-GAAP constant currency operating margin as Non-GAAP constant currency income from operations as a percentage of constant currency net revenues. |
|
|
(+) |
Changes and percentages are based on actual values. Certain tables may not sum or recalculate due to rounding. Refer to "About Non-GAAP Financial Measures" section of press release. |
|
|
|
||||||||||||||||
|
UNAUDITED GAAP TO NON-GAAP RECONCILIATION CONTINUED+ |
||||||||||||||||
|
FINANCIAL MEASURES OTHER THAN CONSTANT CURRENCY |
||||||||||||||||
|
(in thousands, except per share data) |
||||||||||||||||
|
|
Three Months Ended
|
Nine Months Ended
|
||||||||||||||
|
|
2026 |
2025 |
2026 |
2025 |
||||||||||||
|
GAAP gross profit |
$ |
697,471 |
|
$ |
639,201 |
|
$ |
2,191,488 |
|
$ |
2,027,426 |
|
||||
|
Stock-based compensation |
|
1,819 |
|
|
1,540 |
|
|
5,285 |
|
|
4,714 |
|
||||
|
Amortization of intangibles (1) |
|
3,559 |
|
|
3,837 |
|
|
11,282 |
|
|
11,138 |
|
||||
|
Restructuring and other charges (2) |
|
11,230 |
|
|
4,792 |
|
|
11,308 |
|
|
7,045 |
|
||||
|
Impairment loss on Assets held for sale (3) |
|
— |
|
|
23,142 |
|
|
— |
|
|
23,142 |
|
||||
|
Gain on Assets held for sale (3) |
|
— |
|
|
— |
|
|
(11,699 |
) |
|
— |
|
||||
|
Depreciation on assets disposed of in connection with restructuring plans (4) |
|
— |
|
|
13,663 |
|
|
15,599 |
|
|
13,663 |
|
||||
|
Impairment loss on inventory (5) |
|
— |
|
|
14,924 |
|
|
— |
|
|
14,924 |
|
||||
|
Other non-GAAP items (6) |
|
— |
|
|
— |
|
|
841 |
|
|
— |
|
||||
|
Non-GAAP gross profit |
$ |
714,079 |
|
$ |
701,099 |
|
$ |
2,224,104 |
|
$ |
2,102,052 |
|
||||
|
|
|
|
|
|
||||||||||||
|
GAAP gross margin |
|
68.7 |
% |
|
64.2 |
% |
|
70.4 |
% |
|
67.9 |
% |
||||
|
Non-GAAP gross margin |
|
70.4 |
% |
|
70.4 |
% |
|
71.5 |
% |
|
70.4 |
% |
||||
|
|
|
|
|
|
||||||||||||
|
GAAP total operating expenses |
$ |
528,307 |
|
$ |
542,903 |
|
$ |
1,726,356 |
|
$ |
1,636,995 |
|
||||
|
Stock-based compensation |
|
(37,208 |
) |
|
(46,837 |
) |
|
(120,226 |
) |
|
(136,868 |
) |
||||
|
Amortization of intangibles (1) |
|
(930 |
) |
|
(939 |
) |
|
(2,827 |
) |
|
(2,684 |
) |
||||
|
Restructuring and other charges (2) |
|
(17,231 |
) |
|
(31,827 |
) |
|
(16,476 |
) |
|
(31,630 |
) |
||||
|
Legal settlements and contingencies (7) |
|
(6,649 |
) |
|
— |
|
|
(75,995 |
) |
|
(4,178 |
) |
||||
|
Non-GAAP total operating expenses |
$ |
466,289 |
|
$ |
463,300 |
|
$ |
1,510,832 |
|
$ |
1,461,635 |
|
||||
|
|
|
|
|
|
||||||||||||
|
GAAP income from operations |
$ |
169,164 |
|
$ |
96,298 |
|
$ |
465,132 |
|
$ |
390,431 |
|
||||
|
Stock-based compensation |
|
39,027 |
|
|
48,377 |
|
|
125,511 |
|
|
141,582 |
|
||||
|
Amortization of intangibles (1) |
|
4,489 |
|
|
4,776 |
|
|
14,109 |
|
|
13,822 |
|
||||
|
Restructuring and other charges (2) |
|
28,461 |
|
|
36,619 |
|
|
27,784 |
|
|
38,675 |
|
||||
|
Legal settlements and contingencies (7) |
|
6,649 |
|
|
— |
|
|
75,995 |
|
|
4,178 |
|
||||
|
Impairment loss on Assets held for sale (3) |
|
— |
|
|
23,142 |
|
|
— |
|
|
23,142 |
|
||||
|
Gain on Assets held for Sale(3) |
|
— |
|
|
— |
|
|
(11,699 |
) |
|
— |
|
||||
|
Depreciation on assets disposed of in connection with restructuring plans (4) |
|
— |
|
|
13,663 |
|
|
15,599 |
|
|
13,663 |
|
||||
|
Impairment loss on inventory (5) |
|
— |
|
|
14,924 |
|
|
— |
|
|
14,924 |
|
||||
|
Other non-GAAP items (6) |
|
— |
|
|
— |
|
|
841 |
|
|
— |
|
||||
|
Non-GAAP income from operations |
$ |
247,790 |
|
$ |
237,799 |
|
$ |
713,272 |
|
$ |
640,417 |
|
||||
|
|
|
|
|
|
||||||||||||
|
GAAP operating margin |
|
16.7 |
% |
|
9.7 |
% |
|
15.0 |
% |
|
13.1 |
% |
||||
|
Non-GAAP operating margin |
|
24.4 |
% |
|
23.9 |
% |
|
22.9 |
% |
|
21.4 |
% |
||||
|
|
Three Months Ended
|
Nine Months Ended
|
||||||||||||||
|
|
2026 |
2025 |
2026 |
2025 |
||||||||||||
|
GAAP net income before provision for income taxes |
$ |
170,074 |
|
$ |
94,734 |
|
$ |
467,653 |
|
$ |
408,692 |
|
||||
|
Stock-based compensation |
|
39,027 |
|
|
48,377 |
|
|
125,511 |
|
|
141,582 |
|
||||
|
Amortization of intangibles (1) |
|
4,489 |
|
|
4,776 |
|
|
14,109 |
|
|
13,822 |
|
||||
|
Restructuring and other charges (2) |
|
28,461 |
|
|
36,619 |
|
|
27,784 |
|
|
38,675 |
|
||||
|
Legal settlements and contingencies (7) |
|
6,649 |
|
|
— |
|
|
75,995 |
|
|
4,178 |
|
||||
|
Impairment loss on Assets held for sale (3) |
|
— |
|
|
23,142 |
|
|
— |
|
|
23,142 |
|
||||
|
Gain on Assets held for sale (3) |
|
— |
|
|
— |
|
|
(11,699 |
) |
|
— |
|
||||
|
Depreciation on assets disposed of in connection with restructuring plans (4) |
|
— |
|
|
13,663 |
|
|
15,599 |
|
|
13,663 |
|
||||
|
Impairment loss on inventory (5) |
|
— |
|
|
14,924 |
|
|
— |
|
|
14,924 |
|
||||
|
Other non-GAAP items (6) |
|
— |
|
|
— |
|
|
841 |
|
|
— |
|
||||
|
Non-GAAP net income before provision for income taxes |
$ |
248,700 |
|
$ |
236,235 |
|
$ |
715,793 |
|
$ |
658,678 |
|
||||
|
|
|
|
|
|
||||||||||||
|
GAAP provision for income taxes |
$ |
35,030 |
|
$ |
37,981 |
|
$ |
111,544 |
|
$ |
134,101 |
|
||||
|
Tax impact on non-GAAP adjustments |
|
14,763 |
|
|
9,266 |
|
|
31,614 |
|
|
(2,365 |
) |
||||
|
Non-GAAP provision for income taxes |
$ |
49,793 |
|
$ |
47,247 |
|
$ |
143,158 |
|
$ |
131,736 |
|
||||
|
|
|
|
|
|
||||||||||||
|
GAAP effective tax rate |
|
20.6 |
% |
|
40.1 |
% |
|
23.9 |
% |
|
32.8 |
% |
||||
|
Non-GAAP effective tax rate |
|
20.0 |
% |
|
20.0 |
% |
|
20.0 |
% |
|
20.0 |
% |
||||
|
|
|
|
|
|
||||||||||||
|
GAAP net income |
$ |
135,044 |
|
$ |
56,753 |
|
$ |
356,109 |
|
$ |
274,591 |
|
||||
|
Stock-based compensation |
|
39,027 |
|
|
48,377 |
|
|
125,511 |
|
|
141,582 |
|
||||
|
Amortization of intangibles (1) |
|
4,489 |
|
|
4,776 |
|
|
14,109 |
|
|
13,822 |
|
||||
|
Restructuring and other charges (2) |
|
28,461 |
|
|
36,619 |
|
|
27,784 |
|
|
38,675 |
|
||||
|
Legal settlements and contingencies (7) |
|
6,649 |
|
|
— |
|
|
75,995 |
|
|
4,178 |
|
||||
|
Impairment loss on Assets held for sale (3) |
|
— |
|
|
23,142 |
|
|
— |
|
|
23,142 |
|
||||
|
Gain on Assets held for sale (3) |
|
— |
|
|
— |
|
|
(11,699 |
) |
|
— |
|
||||
|
Depreciation on assets disposed of in connection with restructuring plans (4) |
|
— |
|
|
13,663 |
|
|
15,599 |
|
|
13,663 |
|
||||
|
Impairment loss on inventory (5) |
|
— |
|
|
14,924 |
|
|
— |
|
|
14,924 |
|
||||
|
Other non-GAAP items (6) |
|
— |
|
|
— |
|
|
841 |
|
|
— |
|
||||
|
Tax impact on non-GAAP adjustments |
|
(14,763 |
) |
|
(9,266 |
) |
|
(31,614 |
) |
|
2,365 |
|
||||
|
Non-GAAP net income |
$ |
198,907 |
|
$ |
188,988 |
|
$ |
572,635 |
|
$ |
526,942 |
|
||||
|
|
|
|
|
|
||||||||||||
|
GAAP diluted net income per share |
$ |
1.90 |
|
$ |
0.78 |
|
$ |
4.98 |
|
$ |
3.77 |
|
||||
|
Non-GAAP diluted net income per share |
$ |
2.80 |
|
$ |
2.61 |
|
$ |
8.01 |
|
$ |
7.23 |
|
||||
|
|
|
|
|
|
||||||||||||
|
Shares used in computing diluted net income per share |
|
71,015 |
|
|
72,419 |
|
|
71,473 |
|
|
72,880 |
|
||||
|
Notes: |
||
|
(1) |
Amortization of intangible assets. |
|
|
(2) |
During the third quarter of 2026 and 2025, we initiated restructuring plans to reduce headcount and increase efficiency across the organization and lower the overall cost structure. Restructuring charges are primarily related to involuntary termination benefits, including employee severance and other post-employment benefits. |
|
|
(3) |
During the third quarter 2025, we originally recorded an impairment loss related to a manufacturing facility disposal group that met the criteria to be classified as assets held for sale. During the first quarter of 2026, we recognized a gain of |
|
|
(4) |
During the third quarter 2025, we initiated the disposal of certain manufacturing fixed assets, in connection with our 2025 restructuring plan. Accordingly, we revised the useful lives of these assets and recorded accelerated depreciation expense. |
|
|
(5) |
During the third quarter 2025, we recorded an impairment loss for obsolete inventory. |
|
|
(6) |
During the first quarter 2026, we recorded other non-recurring charges related to the disposal of certain manufacturing fixed assets. |
|
|
(7) |
During the third quarter 2026, and second quarter 2026, we recorded approximately |
|
|
(+) |
Changes and percentages are based on actual values. Certain tables may not sum or recalculate due to rounding. Refer to "About Non-GAAP Financial Measures" section of press release. |
|
|
|
||
|
Q4 2026 OUTLOOK - GAAP TO NON-GAAP RECONCILIATION |
||
|
GAAP gross margin |
~71.1%-71.4% |
|
|
Stock-based compensation |
~0.2% |
|
|
Amortization of intangibles (1) |
~0.4% |
|
|
Other charges (2) |
~0.2% |
|
|
Non-GAAP gross margin |
Approximately 72.0% |
|
|
Percentages do not add up due to rounding. |
||
|
Notes: |
||
|
(1) |
Amortization of intangible assets. |
|
|
(2) |
In the fourth quarter 2026, we anticipate one-time charge of approximately |
|
|
GAAP operating margin |
~19.6%-20.0% |
|
|
Stock-based compensation |
~4.9% |
|
|
Amortization of intangibles (1) |
~0.4% |
|
|
Restructuring and other charges (2) |
~0.7%-0.9% |
|
|
Non-GAAP operating margin |
Approximately 26.0% |
|
|
Percentages do not add up due to rounding. |
||
|
Notes: |
||
|
(1) |
Amortization of intangible assets. |
|
|
(2) |
In the fourth quarter 2026, we anticipate incurring restructuring and other charges of approximately |
|
|
|
||
|
FISCAL 2026 OUTLOOK - GAAP TO NON-GAAP RECONCILIATION |
||
|
|
||
|
GAAP operating margin |
~16.1%-16.2% |
|
|
Stock-based compensation |
~4.2% |
|
|
Amortization of intangibles (1) |
~0.5% |
|
|
Depreciation on assets disposed of in connection with restructuring plans (2) |
~0.4% |
|
|
Gain on Assets held for sale (3) |
~(0.3%) |
|
|
Legal settlement and contingencies loss (4) |
~1.8% |
|
|
Restructuring and other charges (5) |
~0.9% |
|
|
Non-GAAP operating margin |
~23.7% |
|
|
Percentages do not add up due to rounding. |
||
|
Notes: |
||
|
(1) |
Amortization of intangible assets. |
|
|
(2) |
First quarter 2026, we initiated the disposal of certain manufacturing fixed assets, in connection with our 2025 restructuring plan. Accordingly, we revised the useful lives of these assets and recorded accelerated depreciation expense. |
|
|
(3) |
During the third quarter 2025, we originally recorded an impairment loss related to a manufacturing facility disposal group that met the criteria to be classified as assets held for sale. During the first quarter of 2026, we recognized a gain of |
|
|
(4) |
During the third quarter 2026, and second quarter 2026, we recorded approximately |
|
|
(5) |
Restructuring charges are primarily related to involuntary termination benefits, including employee severance and other post-employment benefits. |
|
|
Refer to "About Non-GAAP Financial Measures" section of press release. |
||
View source version on businesswire.com: https://www.businesswire.com/news/home/20261027432827/en/
(909) 833-5839
mvalente@aligntech.com
(828) 551-4201
sarah.karlson@zenogroup.com
Source: